Summary

Persistence Market Research has recently released a comprehensive report on the global Bioanalytical Testing Services Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Bioanalytical Testing Services Market Size (2025E): US$ 5.6 Bn
• Projected Market Value (2032F): US$ 10.4 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 9.2%

Bioanalytical Testing Services Market - Report Scope:

The bioanalytical testing services market involves specialized laboratory services used to analyze biological samples in drug development, clinical trials, and pharmaceutical research. These services play a critical role in evaluating pharmacokinetics, pharmacodynamics, bioavailability, and bioequivalence of drug candidates. With the increasing complexity of biologics and biosimilars, along with growing clinical trial activities globally, demand for accurate and regulatory-compliant bioanalytical testing services is rising significantly. The market is also being driven by outsourcing trends among pharmaceutical and biotechnology companies to reduce costs and improve efficiency.

Market Growth Drivers:

Several key factors are fueling the growth of the global bioanalytical testing services market. The rising number of clinical trials worldwide, particularly for biologics and biosimilars, is significantly increasing demand for advanced analytical testing solutions. Growing outsourcing activities by pharmaceutical and biotechnology companies to contract research organizations (CROs) are further accelerating market expansion. In addition, stringent regulatory requirements for drug approval by agencies such as the FDA and EMA are driving the need for highly accurate and compliant testing services. Technological advancements in analytical instrumentation and increasing investment in drug development pipelines are also supporting market growth.

Market Restraints:

Despite strong growth potential, the bioanalytical testing services market faces certain challenges. High operational costs associated with advanced analytical technologies and skilled workforce requirements can limit accessibility for smaller firms. Strict regulatory compliance and complex approval procedures may also delay project timelines. Additionally, concerns related to data integrity, reproducibility of results, and variability in biological samples can pose challenges for service providers and impact market efficiency.

Market Opportunities:

The bioanalytical testing services market presents significant growth opportunities driven by the increasing adoption of biologics, gene therapies, and personalized medicine. Expansion of clinical research activities in emerging markets such as Asia-Pacific and Latin America offers strong potential for service providers. Growing demand for outsourcing services from pharmaceutical companies seeking cost-effective and specialized expertise is further opening new avenues. Additionally, advancements in high-throughput technologies, automation, and biomarker-based testing are expected to create new opportunities for innovation and market expansion.

Key Questions Answered in the Report:

• What are the primary factors driving the global bioanalytical testing services market's growth?
• Which regions and market segments are experiencing the highest demand for bioanalytical testing services?
• How are advancements in analytical technologies influencing market dynamics?
• Who are the key players in the bioanalytical testing services market, and what strategies are they adopting to stay competitive?
• What are the emerging trends and future projections for the global bioanalytical testing services market?

Competitive Intelligence and Business Strategy:

Leading companies in the global bioanalytical testing services market are focusing on expanding their service portfolios, investing in advanced analytical technologies, and strengthening global laboratory networks. Strategic collaborations with pharmaceutical and biotechnology firms are enabling faster and more efficient drug development processes. Companies are also emphasizing automation, data accuracy, and regulatory compliance to enhance service quality and reliability. Expansion into emerging markets and continuous investment in R&D are key strategies adopted to maintain a competitive advantage.

Companies Covered in This Report:

• Thermo Fisher Scientific Inc.
• Charles River Laboratories International
• ICON Plc
• Syneos Health
• IQVIA Inc.
• Pace Analytical Services LLC
• Intertek Group Plc
• SGS SA
• Wuxi AppTec
• Labcorp

Market Segmentation:

By Molecule:

• Small Molecule
• Large Molecule

By Test:

• ADME
• Pharmacokinetics (PK)
• Pharmacodynamics (PD)
• Bioavailability
• Bioequivalence
• Biomarker Testing
• Cell-based Assay
• Virology Testing
• Other Tests

By Workflow:

• Sample Collection and Preparation
• Method Development and Validation
• Sample Analysis
• Other Processes

By End-user:

• Pharma and Biopharma Companies
• CDMO
• CRO
• Others

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Bioanalytical Testing Services Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-economic Factors
2.3.1. Expansion of Personalized Medicine and Rare Disease Therapies
2.3.2. Globalization of Clinical Trials and Cross-border Studies
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Test Type Demand Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
4. Global Bioanalytical Testing Services Market Outlook
4.1. Key Highlights
4.1.1. Market Volume (Units) Projections
4.1.2. Market Size (US$ Bn) and Y-o-Y Growth
4.1.3. Absolute $ Opportunity
4.2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Bioanalytical Testing Services Market Outlook: Molecule
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Molecule, 2019-2024
4.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Molecule, 2025-2032
4.3.3.1. Small Molecule
4.3.3.2. Large Molecule
4.3.4. Market Attractiveness Analysis: Molecule
4.4. Global Bioanalytical Testing Services Market Outlook: Test
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Test, 2019-2024
4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
4.4.3.1. ADME
4.4.3.2. Pharmacokinetics (PK)
4.4.3.3. Pharmacodynamics (PD)
4.4.3.4. Bioavailability
4.4.3.5. Bioequivalence
4.4.3.6. Biomarker Testing
4.4.3.7. Cell-based Assay
4.4.3.8. Virology Testing
4.4.3.9. Other Tests
4.4.4. Market Attractiveness Analysis: Test
4.5. Global Bioanalytical Testing Services Market Outlook: Workflow
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Workflow, 2019-2024
4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2025-2032
4.5.3.1. Sample Collection and Preparation
4.5.3.2. Method Development and Validation
4.5.3.3. Sample Analysis
4.5.3.4. Other Processes
4.5.4. Market Attractiveness Analysis: Workflow
4.6. Global Bioanalytical Testing Services Market Outlook: End-user
4.6.1. Introduction / Key Findings
4.6.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
4.6.3. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
4.6.3.1. Pharma and Biopharma Companies
4.6.3.2. CDMO
4.6.3.3. CRO
4.6.3.4. Others
4.6.4. Market Attractiveness Analysis: End-user
5. Global Bioanalytical Testing Services Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Bioanalytical Testing Services Market Outlook
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
6.2.1. By Country
6.2.2. By Molecule
6.2.3. By Test
6.2.4. By Workflow
6.2.5. By End-user
6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
6.3.1. U.S.
6.3.2. Canada
6.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Molecule, 2025-2032
6.4.1. Small Molecule
6.4.2. Large Molecule
6.5. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
6.5.1. ADME
6.5.2. Pharmacokinetics (PK)
6.5.3. Pharmacodynamics (PD)
6.5.4. Bioavailability
6.5.5. Bioequivalence
6.5.6. Biomarker Testing
6.5.7. Cell-based Assay
6.5.8. Virology Testing
6.5.9. Other Tests
6.6. Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2025-2032
6.6.1. Sample Collection and Preparation
6.6.2. Method Development and Validation
6.6.3. Sample Analysis
6.6.4. Other Processes
6.7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
6.7.1. Pharma and Biopharma Companies
6.7.2. CDMO
6.7.3. CRO
6.7.4. Others
6.8. Market Attractiveness Analysis
7. Europe Bioanalytical Testing Services Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Molecule
7.2.3. By Test
7.2.4. By Workflow
7.2.5. By End-user
7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkey
7.3.8. Rest of Europe
7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Molecule, 2025-2032
7.4.1. Small Molecule
7.4.2. Large Molecule
7.5. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
7.5.1. ADME
7.5.2. Pharmacokinetics (PK)
7.5.3. Pharmacodynamics (PD)
7.5.4. Bioavailability
7.5.5. Bioequivalence
7.5.6. Biomarker Testing
7.5.7. Cell-based Assay
7.5.8. Virology Testing
7.5.9. Other Tests
7.6. Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2025-2032
7.6.1. Sample Collection and Preparation
7.6.2. Method Development and Validation
7.6.3. Sample Analysis
7.6.4. Other Processes
7.7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
7.7.1. Pharma and Biopharma Companies
7.7.2. CDMO
7.7.3. CRO
7.7.4. Others
7.8. Market Attractiveness Analysis
8. East Asia Bioanalytical Testing Services Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Molecule
8.2.3. By Test
8.2.4. By Workflow
8.2.5. By End-user
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Molecule, 2025-2032
8.4.1. Small Molecule
8.4.2. Large Molecule
8.5. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
8.5.1. ADME
8.5.2. Pharmacokinetics (PK)
8.5.3. Pharmacodynamics (PD)
8.5.4. Bioavailability
8.5.5. Bioequivalence
8.5.6. Biomarker Testing
8.5.7. Cell-based Assay
8.5.8. Virology Testing
8.5.9. Other Tests
8.6. Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2025-2032
8.6.1. Sample Collection and Preparation
8.6.2. Method Development and Validation
8.6.3. Sample Analysis
8.6.4. Other Processes
8.7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
8.7.1. Pharma and Biopharma Companies
8.7.2. CDMO
8.7.3. CRO
8.7.4. Others
8.8. Market Attractiveness Analysis
9. South Asia & Oceania Bioanalytical Testing Services Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Molecule
9.2.3. By Test
9.2.4. By Workflow
9.2.5. By End-user
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Molecule, 2025-2032
9.4.1. Small Molecule
9.4.2. Large Molecule
9.5. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
9.5.1. ADME
9.5.2. Pharmacokinetics (PK)
9.5.3. Pharmacodynamics (PD)
9.5.4. Bioavailability
9.5.5. Bioequivalence
9.5.6. Biomarker Testing
9.5.7. Cell-based Assay
9.5.8. Virology Testing
9.5.9. Other Tests
9.6. Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2025-2032
9.6.1. Sample Collection and Preparation
9.6.2. Method Development and Validation
9.6.3. Sample Analysis
9.6.4. Other Processes
9.7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
9.7.1. Pharma and Biopharma Companies
9.7.2. CDMO
9.7.3. CRO
9.7.4. Others
9.8. Market Attractiveness Analysis
10. Latin America Bioanalytical Testing Services Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Molecule
10.2.3. By Test
10.2.4. By Workflow
10.2.5. By End-user
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Molecule, 2025-2032
10.4.1. Small Molecule
10.4.2. Large Molecule
10.5. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
10.5.1. ADME
10.5.2. Pharmacokinetics (PK)
10.5.3. Pharmacodynamics (PD)
10.5.4. Bioavailability
10.5.5. Bioequivalence
10.5.6. Biomarker Testing
10.5.7. Cell-based Assay
10.5.8. Virology Testing
10.5.9. Other Tests
10.6. Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2025-2032
10.6.1. Sample Collection and Preparation
10.6.2. Method Development and Validation
10.6.3. Sample Analysis
10.6.4. Other Processes
10.7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
10.7.1. Pharma and Biopharma Companies
10.7.2. CDMO
10.7.3. CRO
10.7.4. Others
10.8. Market Attractiveness Analysis
11. Middle East & Africa Bioanalytical Testing Services Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Molecule
11.2.3. By Test
11.2.4. By Workflow
11.2.5. By End-user
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Molecule, 2025-2032
11.4.1. Small Molecule
11.4.2. Large Molecule
11.5. Market Size (US$ Bn) Analysis and Forecast, By Test, 2025-2032
11.5.1. ADME
11.5.2. Pharmacokinetics (PK)
11.5.3. Pharmacodynamics (PD)
11.5.4. Bioavailability
11.5.5. Bioequivalence
11.5.6. Biomarker Testing
11.5.7. Cell-based Assay
11.5.8. Virology Testing
11.5.9. Other Tests
11.6. Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2025-2032
11.6.1. Sample Collection and Preparation
11.6.2. Method Development and Validation
11.6.3. Sample Analysis
11.6.4. Other Processes
11.7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
11.7.1. Pharma and Biopharma Companies
11.7.2. CDMO
11.7.3. CRO
11.7.4. Others
11.8. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2024
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Thermo Fisher Scientific Inc.
12.3.1.1. Overview
12.3.1.2. Segments and Molecule
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Charles River Laboratories International
12.3.3. ICON Plc
12.3.4. Syneos Health
12.3.5. IQVIA Inc.
12.3.6. Pace Analytical Services LLC
12.3.7. Intertek Group Plc
12.3.8. SGS SA
12.3.9. Wuxi AppTec
12.3.10. Labcorp
12.3.11. Others
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations